Longitudinal study of the frequency of cytotoxic T cell precursors in kidney allograft recipients

被引:20
作者
Mestre, M
Massip, E
Bas, J
Alsina, J
Romeu, A
Castelao, AM
Buendia, E
Grinyo, JM
机构
[1] CIUTAT SANITARIA & UNIV BELLVITGE,SERV IMMUNOL,BARCELONA,SPAIN
[2] CIUTAT SANITARIA & UNIV BELLVITGE,SERV NEPHROL,BARCELONA,SPAIN
关键词
limiting dilution assay; kidney; transplantation; clonal deletion;
D O I
10.1046/j.1365-2249.1996.d01-657.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clonal deletion or inactivation of donor-specific alloreactive cells are important mechanisms that are believed to account for acquired immune tolerance in allograft recipients. Serial assessment of precursor cytotoxic T lymphocyte frequencies (CTLpf) by limiting dilution analysis (LDA) provides information at the clonal level on changes in the alloimmune response of graft recipients. We performed a longitudinal study of 15 cadaveric kidney recipients before and every 3 months throughout the first year after transplantation (Tx). Pre-Tx values of donor CTLpf showed high interindividual variability without a predictive value for the clinical outcome. All patients with well functioning kidneys had decreased CTLpf at 3 months post-Tx in comparison with pre-Tx values. This decrease was donor-specific in four patients and was permanent in two cases throughout the study. Most patients presented decreased anti-donor CTLpf values from 6 to 9 months, whereas a partial recovery of donor CTLpf was observed in three patients. Reversible acute rejection was diagnosed in three patients, and it was associated with a marked increase in anti-donor CTLpf, returning to pre-Tx values by 9 months post-Tx. In addition, one patient with chronic rejection displayed a transient increase in CTLpf 6 months after Tx. The results of this sequential study indicate the establishment of a state of either hyporesponsiveness or functional clonal inactivation, transient or permanent, which could facilitate allograft acceptance.
引用
收藏
页码:108 / 114
页数:7
相关论文
共 25 条
[1]  
BAS J, 1992, TRANSPLANT P, V24, P76
[2]  
Bas J, 1993, Allergol Immunopathol (Madr), V21, P136
[3]  
EBERSPACHER MLL, 1994, TRANSPLANTATION, V57, P1746
[4]  
FAZEKAS S, 1982, J IMMUNOL METHODS, V49, P11
[5]   ANTILYMPHOCYTE GLOBULIN VERSUS OKT3 INDUCTION THERAPY IN CADAVERIC KIDNEY-TRANSPLANTATION - A PROSPECTIVE RANDOMIZED STUDY [J].
GRINO, JM ;
CASTELAO, AM ;
SERON, D ;
GONZALEZ, C ;
GALCERAN, JM ;
GILVERNET, S ;
ANDRES, E ;
MESTRE, M ;
TORRAS, J ;
ALSINA, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (06) :603-610
[6]   SUPPRESSOR T-CELLS IN ALLOGENEIC MODELS [J].
HUTCHINSON, IV .
TRANSPLANTATION, 1986, 41 (05) :547-555
[7]   OPTIMIZING A LIMITING DILUTION CULTURE SYSTEM FOR QUANTITATING FREQUENCIES OF ALLOREACTIVE CYTOTOXIC LYMPHOCYTE-T PRECURSORS [J].
KAMINSKI, E ;
HOWS, J ;
GOLDMAN, J ;
BATCHELOR, R .
CELLULAR IMMUNOLOGY, 1991, 137 (01) :88-95
[8]  
KAMINSKI E, 1988, BONE MARROW TRANSPL, V3, P149
[9]   T-CELL TOLERANCE BY CLONAL ELIMINATION IN THE THYMUS [J].
KAPPLER, JW ;
ROEHM, N ;
MARRACK, P .
CELL, 1987, 49 (02) :273-280
[10]  
KENYON NS, 1989, TRANSPLANT P, V21, P336